Axtria Ignite 2025: Building on GenAI’s foundation with agen...
Hundreds of senior executives representing major pharma companies met last month at Axtria Ignite 2025 to discuss the future of agentic AI in the industry.
mRNA ‘wake-up call’ shows promise as universal cancer vaccin...
Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit
AZ boasts phase 3 win for self-administered gMG drug
Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
EC clears first treatment for high-risk smouldering multiple...
Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Revolutionising Clinical Trials: Evolution Summit 2025 Retur...
Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers
Welcome to the 3rd Spatial Biology for Drug Development Summ...
Transforming Research & Development with Faster, More Precise Spatial Insights
2nd Hit ID Summit
Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.
Unlocking the Potential of Targeting the Innate Immune Syste...
Ready to Catalyze the Next Wave of Inflammasome Therapies?
The Inaugural Market Access for CNS Therapeutics Summit Has ...
The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...